India's new clinical trial rules establish an accelerated pathway for new drug approvals, but affordability remains… https://t.co/uhVXDZGLfr
Customer Logins
Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.
Customer Logins
2018 ISPOR Europe research on IRP
14 November 2018
Cameron Lockwood
On Tuesday, we presented research at the ISPOR Europe meeting in Barcelona by Cameron Lockwood. The research looks at how liberally (or sparingly) IRP should be utilized. Fascinating research in light of the recent IRP announcements from the US
Related Posts
-
-
-
-
-
-
-
-
Explore
RELATED INDUSTRIES & TOPICS
Follow Us
Democrats explore creative ways to expand health insurance access with Medicare X https://t.co/kAsNBvtiuz
The creation of the Canadian Drug Agency and Pharmacare could mean big changes for drug prices https://t.co/8uMsHLXiAE
Norway’s Statistik Sentralbyrå (SSB) annual healthcare and pharmaceutical expenditure statistics confirms the accur… https://t.co/laLzZbrc79